Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 1-17

  Naqshbandi, Mariam ^a   Harris, Stewart B ^a   Esler, James G ^a   Antwi Nsiah, Fred ^b  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cardiovascular disease; Diabetes; Diabetes mellitus; End stage renal disease; Indigenous; Lower extremity amputations; Macrovascular; Microvascular; Mortality; Nephropathy; Neuropathy; Retinopathy; Type 2 diabetes

Indexed keywords

AUSTRALIA; CANADA; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CULTURAL ANTHROPOLOGY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; INDIGENOUS PEOPLE; LEG AMPUTATION; MICROALBUMINURIA; MORTALITY; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTHERN MARIANA ISLANDS; PREVALENCE; REVIEW; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANADA; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; HUMANS; INDIANS, NORTH AMERICAN; MIDDLE AGED; OCEANIC ANCESTRY GROUP; UNITED STATES; YOUNG ADULT;

EID: 52949112278     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.07.017     Document Type: Review

References (137)

1. Jarrett R.J. Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol. Rev. 11 (1989) 151-171
2. Young T.K., Reading J., Elias B., and O'Neil J. Type 2 diabetes mellitus in Canada's First Nations: Status of an epidemic in progress. CMAJ 163 5 (2000) 561-566
3. Young T.K., Schraer C.D., Shubnikoff E.V., Szathmary E.J., and Nikitin Y.P. Prevalence of diagnosed diabetes in circumpolar Indigenous populations. Int. J. Epidemiol. 21 4 (1992) 730-736
4. Howard B.V., Lee E.T., Cowan L.D., Devereux R.B., Galloway J.M., Go O.T., et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 99 18 (1999) 2389-2395
5. Delisle H.F., and Ekoe J.M. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec. CMAJ 148 1 (1993) 41-47
6. Harris S.B., Gittelsohn J., Hanley A.J.G., Barnie A., Wolever T.M.S., Gao X.J., et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 20 (1997) 185-187
7. Ferreira M.L., and Lang G.C. Indigenous Peoples and Diabetes: Community Empowerment and Wellness (2006), Carolina Academic Press, Durham, North Carolina
8. Gohdes D., Schraer C., and Rith-Najarian S. Diabetes prevention in American Indians and Alaska Natives: Where are we in 1994?. Diabetes Res. Clin. Pract. 34 Suppl. (1996) S95-100
9. Gohdes D., Kaufman S., and Valway S. Diabetes in American Indians: an overview. Diabetes Care 16 1 (1993) 239-243
10. Yu C.H., and Zinman B. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Res. Clin. Pract. 78 2 (2007) 159-170
11. Neel J.V. The thrifty genotype revisited. The Genetics of Diabetes Mellitus (1985), Academy Press
12. Hegele R.A., and Bartlett L.C. Genetics, environment and Type 2 Diabetes in the Oji-Cree population of northern Ontario. Can. J. Diabetes 27 3 (2003) 256-261
13. Gracey M.S. Nutrition-related disorders in Indigenous Australians: how things have changed. Med. J. Aust. 186 1 (2007) 15-17
14. Baiju R.S., Gunraj N., and Hux J.E. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am. J. Public Health 93 5 (2003) 798-802
15. Mak D.B., Whitehead S., and Plant A.J. So far and yet so close: quality of management of diabetes in Australian and Canadian Indigenous communities. Aust. J. Rural Health 12 5 (2004) 206-209
16. Shannon C. Acculturation: Aboriginal and Torres Strait Islander nutrition. Asia Pac. J. Clin. Nutr. 11 Suppl. 3 (2002) S576-S578
17. McDermott R.A. EBM and the health of Indigenous Australians. Med. J. Aust. 175 1 (2001) 35-37
18. Shah B.R., Gunraj N., and Hux J.E. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am. J. Public Health 93 5 (2003) 798-802
19. Garro L.C. Cultural meaning, explanations of illness, and the development of comparative frameworks. Ethnology 39 4 (2000) 305-334
20. Brassard P., Robinson E., and Dumont C. Descriptive epidemiology of non-insulin-dependent diabetes mellitus in the James Bay Cree population of Quebec, Canada. Arctic Med. Res. 52 2 (1993) 47-54
21. Shah B.R., Hux J.E., and Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch. Intern. Med. 160 12 (2000) 1862-1866
22. Ferreira M.L. Indigenous peoples. In: Skutsch C., and Ryle M. (Eds). Encyclopedia of the World's Minorities (2005), Routledge, New York
23. United Nations, Workshop on data collection and disaggregation for Indigenous peoples: the concept of Indigenous peoples, PFII/2004/WS.1/3 (2004) 1-4.
24. Seymour-Smith C. Dictionary of Anthropology (1986), G.K. Hall, Boston, Mass
25. Cunningham C., and Stanley F. Indigenous by definition, experience, or world view. BMJ 327 7412 (2003) 403-404
26. Wilson R., Krefting L.H., Sutcliffe P., and VanBussel L. Incidence and prevalence of end-stage renal disease among Ontario's James Bay Cree. Can. J. Public Health 83 2 (1992) 143-146
27. Dyck R.F., and Tan L. Rates and outcomes of diabetic end-stage renal disease among registered Native People in Saskatchewan. CMAJ 150 2 (1994) 203-208
28. Schraer C.D., Weaver D., Naylor J.L., Provost E., and Mayer A.M. Reduction of amputation rates among Alaska Natives with diabetes following the development of a high-risk foot program. Int. J. Circumpolar Health 63 Suppl. 2 (2004) 114-119
29. Longstreet D.A., Heath D.L., Panaretto K.S., and Vink R. Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians. Rural Remote Health 7 4 (2007) 843
30. Bramley D., Hebert P., Jackson R., and Chassin M. Indigenous disparities in disease-specific mortality, a cross-country comparison: New Zealand, Australia, Canada, and the United States. N. Z. Med. J. 117 1207 (2004) U1215
31. Kunitz S.J. Changing patterns of mortality among American Indians. Am. J. Public Health 98 3 (2008) 404-411
32. Burrows N.R., Narva A.S., Geiss L.S., Engelgau M.M., and Acton K.J. End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001. Diabetes Care 28 5 (2005) 1041-1044
33. Lopes A.A. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure. Adv. Ren. Replace. Ther. 11 1 (2004) 14-23
34. Narva A.S. The spectrum of kidney disease in American Indians. Kidney Int. Suppl. 63 (2003) S3-S7
35. Stidley C.A., Shah V.O., Narva A.S., Dalton D., MacCluer J.W., Bobelu A., et al. A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease. Am. J. Kidney Dis. 39 2 (2002) 358-368
36. Quiggins P.A., and Farrell M.A. Renal disease among the Eastern Band of Cherokee Indians. Diabetes Care 16 1 (1993) 342-345
37. Shultis W.A., Weil E.J., Looker H.C., Curtis J.M., Shlossman M., Genco R.J., et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30 2 (2007) 306-311
38. Schulz L.O., Lalicata M., Carnes D., and Rith-Najarian S.J. Prevalence of diabetes and factors associated with diabetic complications in Oneida Indians. Life Sci. 60 4-5 (1997) 299-306
39. Haswell-Elkins M., Satarug S., O'Rourke P., Moore M., Ng J., McGrath V., et al. Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes. Environ. Res. 106 3 (2008) 379-383
40. Hanley A.J., Harris S.B., Mamakeesick M., Goodwin K., Fiddler E., Hegele R.A., et al. Complications of type 2 diabetes among aboriginal Canadians: prevalence and associated risk factors. Diabetes Care 28 8 (2005) 2054-2057
41. Simmons D., Clover G., and Hope C. Ethnic differences in diabetic retinopathy. Diabetic Med. 24 10 (2007) 1093-1098
42. Freeman W.L., and Hosey G.M. Diabetic complications among American Indians of Washington, Oregon, and Idaho. Prevalence of retinopathy, end-stage renal disease, and amputations. Diabetes Care 16 1 (1993) 357-360
43. Abidi S.M., Negrete H.O., Zahid I., Bennett P.H., and Nelson R.G. Diabetic end-stage renal disease in the Indigenous population of the Commonwealth of the Northern Mariana Islands. Nephrology 10 3 (2005) 291-295
44. Simmons D., Shaw L.M., Scott D.J., Kenealy T., and Scragg R.K. Diabetic nephropathy and microalbuminuria in the community. The South Auckland Diabetes Survey. Diabetes Care 17 12 (1994) 1404-1410
45. Ross S.A., McKenna A., Mozejko S., and Fick G.H. Diabetic retinopathy in Native and nonnative Canadians. Exp. Diabetes Res. 2007 (2007) 1-6
46. Maberley D., Walker H., Koushik A., and Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 168 2 (2003) 160-164
47. McIntyre I., Boughen C., Trepman E., and Embil J.M. Foot and ankle problems of aboriginal and non-aboriginal diabetic patients with end-stage renal disease. Foot Ankle Int. 28 6 (2007) 674-686
48. Durand A.M., Bourne J., Tuohey-Mote D., Khorram K.D., and Abraham I.J. Diabetes in the Indigenous population of the Commonwealth of the Northern Mariana Islands, Asia. Pac. J. Public Health 9 (1996) 28-32
49. Farrell M.A., Quiggins P.A., Eller J.D., Owle P.A., Miner K.M., and Walkingstick E.S. Prevalence of diabetes and its complications in the Eastern Band of Cherokee Indians. Diabetes Care 16 1 (1993) 253-256
50. Lee E.T., Lee V.S., Kingsley R.M., Lu M., Russell D., Asal N.R., et al. Diabetic retinopathy in Oklahoma Indians with NIDDM: incidence and risk factors. Diabetes Care 15 11 (1992) 1620-1627
51. Lee E.T., Lee V.S., Lu M., and Russell D. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes 41 3 (1992) 359-367
52. Murray R.B., Metcalf S.M., Lewis P.M., Mein J.K., and McAllister I.L. Sustaining remote-area programs: retinal camera use by Aboriginal health workers and nurses in a Kimberley partnership. Med. J. Aust. 182 10 (2005) 520-523
53. Maberley D., Cruess A.F., Barile G., and Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthal. Epidemiol. 9 3 (2002) 169-178
54. Chuback J., Embil J.M., Sellers E., Trepman E., Cheang M., and Dean H. Foot abnormalities in Canadian aboriginal adolescents with type 2 diabetes. Diabetes Med. 24 7 (2007) 747-752
55. Hoy W., Light A., and Megill D. Cardiovascular disease in Navajo Indians with type 2 diabetes. Public Health Rep. 110 1 (1995) 87-94
56. Davis T.M., McAullay D., Davis W.A., and Bruce D.G. Characteristics and outcome of type 2 diabetes in urban Aboriginal people: The Fremantle Diabetes Study. Intern. Med. J. 37 1 (2007) 59-63
57. Resnick H.E., Carter E.A., Sosenko J.M., Henly S.J., Fabsitz R.R., Ness F.K., et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care 27 8 (2004) 1885-1891
58. Lee J.S., Lu M., Lee V.S., Russell D., Bahr C., and Lee E.T. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 42 6 (1993) 876-882
59. Simmons D., Scott D., Kenealy T., and Scragg R. Foot care among diabetic patients in south Auckland. N. Z. Med. J. 108 996 (1995) 106-108
60. Young B.A., Maynard C., and Boyko E.J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26 8 (2003) 2392-2399
61. Bhoopatkar H., and Simmons D. Diabetes and hyperglycaemia among patients with congestive cardiac failure in a multiethnic population. N. Z. Med. J. 109 1026 (1996) 268-270
62. Sugarman J.R. Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 14 2 (1991) 139-147
63. Jin A., Martin J.D., and Sarin C. Diabetes mellitus in the First Nations population of British Columbia, Canada. Part 2. Hospital morbidity. Int. J. Circumpolar Health 61 3 (2002) 254-259
64. Durand A.M., Bourne J., Tuohey-Mote D., Khorram K.D., and Abraham I.J. Diabetes in the Indigenous population of the Commonwealth of the Northern Mariana Islands. Asia Pacific J. Public Health 9 (1996) 28-32
65. Hux J.E., and Tang M. Patterns of prevalence and incidence of diabetes. In: Hux J.E., Booth G., Slaughter P.M., and Laupacis A. (Eds). Diabetes in Ontario (2003), Institute for Clinical Evaluative Sciences (ICES) 1.1-1.18
66. Indian Health Service, Interim Report to Congress: Special Diabetes Program for Indians (2004).
67. N. Jaross, P. Ryan, H. Newland, Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2, Clin. Experiment. Ophthalmol. 33 (1) (2005) 26-33.
68. N. Jaross, P. Ryan, H. Newland, Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 1, Clin. Experiment. Ophthalmol. 31 (1) (2003) 32-39.
69. Maberley D.A., King W., Cruess A.F., and Koushik A. Risk factors for diabetic retinopathy in the Cree of James Bay. Ophthal. Epidemiol. 9 3 (2002) 153-167
70. Berinstein D.M., Stahn R.M., Welty T.K., Leonardson G.R., and Herlihy J.J. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care 20 5 (1997) 757-759
71. Griffith S.P., Freeman W.L., Shaw C.J., Mitchell W.H., Olden C.R., Figgs L.D., et al. Screening for diabetic retinopathy in a clinical setting: a comparison of direct ophthalmoscopy by primary care physicians with fundus photography. J. Fam. Pract. 37 1 (1993) 49-56
72. Lee V.S., Kingsley R.M., Lee E.T., Lu M., Russell D., Asal N.R., et al. The diagnosis of diabetic retinopathy: Ophthalmoscopy versus fundus photography. Ophthalmology 100 10 (1993) 1504-1512
73. Liu Q.Z., Pettitt D.J., Hanson R.L., Charles M.A., Klein R., Bennett P.H., et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 36 5 (1993) 428-432
74. Nagi D.K., Pettitt D.J., Bennett P.H., Klein R., and Knowler W.C. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabetes Med. 14 6 (1997) 449-456
75. Chaturvedi N., Stevens L.K., Fuller J.H., Lee E.T., Keen H., Bennett P.H., et al. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes: The WHO multinational study of vascular disease in diabetes. Diabetologia 44 2 (2001) S65-S71
76. Rith-Najarian S., Branchaud C., Beaulieu O., Gohdes D., Simonson G., and Mazze R. Reducing lower-extremity amputations due to diabetes: Application of the staged diabetes management approach in a primary care setting. J. Fam. Pract. 47 2 (1998) 127-132
77. Rith-Najarian S.J., Stolusky T., and Gohdes D.M. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting: A prospective evaluation of simple screening criteria. Diabetes Care 15 10 (1992) 1386-1389
78. Valway S.E., Linkins R.W., and Gohdes D.M. Epidemiology of lower-extremity amputations in the Indian Health Service, 1982-1987. Diabetes Care 16 1 (1993) 349-353
79. Wirth R.B., Marfin A.A., Grau D.W., and Helgerson S.D. Prevalence and risk factors for diabetes and diabetes-related amputations in American Indians in Southern Arizona. Diabetes Care 16 1 (1993) 354-356
80. Young B.A., Maynard C., Reiber G., and Boyko E.J. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care 26 2 (2003) 495-501
81. Kirubakaran M.G. The Central Australian Aboriginal Renal Disease Registry. Nephrology 4 (1998) S83-S85
82. Hegele R.A., Harris S.B., Hanley A.J., and Zinman B. Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clin. Biochem. 32 3 (1999) 201-205
83. Elley C.R., Kenealy T., Robinson E., Bramley D., Selak V., Drury P.L., et al. Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand. Diabetes Res. Clin. Pract. 79 3 (2008) 468-473
84. Tomlin A., Tilyard M., Dawson A., and Dovey S. Health status of New Zealand European, Maori, and Pacific patients with diabetes at 242 New Zealand general practices. N. Z. Med. J. 119 1235 (2006) U2004
85. Lemley K.V., Abdullah I., Myers B.D., Meyer T.W., Blouch K., Smith W.E., et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int. 58 3 (2000) 1228-1237
86. Narva A., Stiles S., Karp S., and Turak A. Access of Native Americans to renal transplantation in Arizona and New Mexico. Blood Purif. 14 4 (1996) 293-304
87. Nelson R.G., Knowler W.C., McCance D.R., Sievers M.L., Pettitt D.J., Charles M.A., et al. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 36 10 (1993) 1087-1093
88. Nelson R.G., Knowler W.C., Pettitt D.J., Hanson R.L., and Bennett P.H. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18 2 (1995) 182-187
89. Shah V.O., Scavini M., Stidley C.A., Tentori F., Welty T.K., MacCluer J.W., et al. Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project. J. Am. Soc. Nephrol. 14 5 (2003) 1320-1329
90. Xu J., Lee E.T., Devereux R.B., Umans J.G., Bella J.N., Shara N.M., et al. A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am. J. Kidney Dis. 51 3 (2008) 415-424
91. Wang Z., and Hoy W.E. Association between diabetes and coronary heart disease in Aboriginal people: Are women disadvantaged?. Med. J. Aust. 180 1 (2004) 508-511
92. Harris S.B., Zinman B., Hanley A., Gittelsohn J., Hegele R., Connelly P.W., et al. The impact of diabetes on cardiovascular risk factors and outcomes in a Native Canadian population. Diabetes Res. Clin. Pract. 55 2 (2002) 165-173
93. Gray R.S., Fabsitz R.R., Cowan L.D., Lee E.T., Howard B.V., and Savage P.J. Risk factor clustering in the insulin resistance syndrome: The Strong Heart Study. Am. J. Epidemiol. 148 9 (1998) 869-878
94. Hoehner C.M., Williams D.E., Sievers M.L., Knowler W.C., Bennett P.H., and Nelson R.G. Trends in heart disease death rates in diabetic and nondiabetic Pima Indians. J. Diabetes Complications 20 1 (2006) 8-13
95. Howard B.V., Roman M.J., Devereux R.B., Fleg J.L., Galloway J.M., Henderson J.A., et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 299 14 (2008) 1678-1689
96. Howard B.V., Best L.G., Galloway J.M., Howard W.J., Jones K., Lee E.T., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29 2 (2006) 391-397
97. Howard B.V. Risk factors for cardiovascular disease in individuals with diabetes: The Strong Heart Study. Acta Diabetol. 33 3 (1996) 180-184
98. Howard B.V., Lee E.T., Cowan L.D., Fabsitz R.R., Howard W.J., Oopik A.J., et al. Coronary heart disease prevalence and its relation to risk factors in American Indians: The Strong Heart Study. Am. J. Epidemiol. 142 3 (1995) 254-268
99. Hu D., Jablonski K.A., Sparling Y.H., Robbins D.C., Lee E.T., Welty T.K., et al. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians: The Strong Heart Study. Ann. Epidemiol. 12 2 (2002) 79-85
100. Lu W.Q., Resnick H.E., Jablonski K.A., Jain A.K., Jones K.L., Robbins D.C., et al. Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study. Diabetes Med. 21 4 (2004) 311-317
101. Nelson R.G., Sievers M.L., Knowler W.C., Swinburn B.A., Pettitt D.J., Saad M.F., et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81 3 (1990) 987-995
102. Okin P.M., Devereux R.B., Lee E.T., Galloway J.M., and Howard B.V. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the Strong Heart Study. Diabetes 53 2 (2004) 434-440
103. Sewell J.L., Malasky B.R., Gedney C.L., Gerber T.M., Brody E.A., Pacheco E.A., et al. The increasing incidence of coronary artery disease and cardiovascular risk factors among a Southwest Native American tribe: the White Mountain Apache Heart Study. Arch. Intern. Med. 162 12 (2002) 1368-1372
104. Phillips C.B., Patel M.S., and Weeramanthri T.S. High mortality from renal disease and infection in Aboriginal central Australians with diabetes. Aust. J. Public Health 19 5 (1995) 482-486
105. Jin A., Martin J.D., and Sarin C. A diabetes mellitus in the First Nations population of British Columbia, Canada. Part 1. Mortality. Int. J. Circumpolar Health 61 3 (2002) 251-253
106. Kerr G.D., Gamble G.D., Doughty R.N., Simmons D., and Baker J. Mortality in individuals with type 2 diabetes and heart disease in a unique New Zealand population. Diabetes Med. 23 12 (2006) 1313-1318
107. Simmons D., Schaumkel J., Cecil A., Scott D.J., and Kenealy T. High impact of nephropathy on five-year mortality rates among patients with Type 2 diabetes mellitus from a multi-ethnic population in New Zealand. Diabetes Med. 16 11 (1999) 926-931
108. Fagot-Campagna A., Hanson R.L., Narayan K.M.V., Sievers M.L., Pettitt D.J., Nelson R.G., et al. Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped association. Circulation 96 5 (1997) 1408-1415
109. Lee E.T., Cowan L.D., Welty T.K., Sievers M., Howard W.J., Oopik A., et al. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988: The Strong Heart Study. Am. J. Epidemiol. 147 11 (1998) 995-1008
110. Lee E.T., Russell D., Jorge N., Kenny S., and Yu M.L. A follow-up study of diabetic Oklahoma Indians: Mortality and causes of death. Diabetes Care 16 1 (1993) 300-305
111. Sievers M.L., Nelson R.G., and Bennett P.H. Sequential trends in overall and cause-specific mortality in diabetic and nondiabetic Pima Indians. Diabetes Care 19 2 (1996) 107-111
112. Sievers M.L., Nelson R.G., Knowler W.C., and Bennett P.H. Impact of NIDDM on mortality and causes of death in Pima Indians. Diabetes Care 15 11 (1992) 1541-1549
113. Tavris D.R., Malek L.L., and Dellinger J.A. Age- and gender-adjusted comparison of Wisconsin native mortality with general Wisconsin population, for diabetes and diabetes-related causes of death-1986-1995. WMJ 97 3 (1998) 58-61
114. Centers for Disease Control and Prevention. End-stage renal disease attributed to diabetes among American Indians/Alaska Natives with diabetes-United States, 1990-1996. JAMA 285 1 (2001) 37-38
115. Muneta B., Newman J., Stevenson J., and Eggers P. Diabetic end-stage renal disease among Native Americans. Diabetes Care 16 1 (1993) 346-348
116. Nelson R.G., Hanson R.L., Pettitt D.J., Knowler W.C., and Bennett P.H. Survival during renal replacement therapy for diabetic end-stage renal disease in Pima Indians. Diabetes Care 19 12 (1996) 1333-1337
117. Newman J.M., Marfin A.A., Eggers P.W., and Helgerson S.D. End-stage renal disease among Native Americans, 1983-86. Am. J. Public Health 80 3 (1990) 318-319
118. Pavkov M.E., Bennett P.H., Knowler W.C., Krakoff J., Sievers M.L., and Nelson R.G. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296 4 (2006) 421-426
119. Pavkov M.E., Knowler W.C., Bennett P.H., Looker H.C., Krakoff J., and Nelson R.G. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int. 70 10 (2006) 1840-1846
120. O'Connor P.J., Crabtree B.F., Nakamura R.M., and Kelley D. Hospitalization experience of Navajo subjects with type II diabetes and matched controls: an historical cohort study. J. Clin. Epidemiol. 43 9 (1990) 881-890
121. Hazel T.J., and Hill P.S. Renal disease in the Aboriginal community of Woorabinda. Aust. J. Rural Health 14 1 (2006) 20-23
122. Morton A.P. Characteristics and outcome of type 2 diabetes in urban Aboriginal people. Intern. Med. J. 37 8 (2007) 581-582 author reply 582-583
123. Simmons D. Impact of an integrated approach to diabetes care at the Rumbalara Aboriginal Health Service. Intern. Med. J. 33 12 (2003) 581-585
124. Reid K.S., Martin B.D., Duerksen F., Nicolle L.E., Garrett M., Simonsen J.N., et al. Diabetic foot complications in a northern Canadian aboriginal community. Foot Ankle Int. 27 12 (2006) 1065-1073
125. Simpson S.H., Corabian P., Jacobs P., and Johnson J.A. The cost of major comorbidity in people with diabetes mellitus. CMAJ 168 13 (2003) 1661-1667
126. Acton K., Rogers B., Campbell G., Johnson C., and Gohdes D. Prevalence of diagnosed diabetes and selected related conditions of six reservations in Montana and Wyoming. Diabetes Care 16 1 (1993) 263-265
127. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23 8 (2000) 1113-1118
128. Hanson R.L., Jacobsson L.T., McCance D.R., Narayan K.M., Pettitt D.J., Bennett P.H., et al. Weight fluctuation, mortality and vascular disease in Pima Indians. Int. J. Obes. Relat. Metab. Disord. 20 5 (1996) 463-471
129. Krakoff J., Hanson R.L., Kobes S., and Knowler W.C. Comparison of the effect of plasma glucose concentrations on microvascular disease between Pima Indian youths and adults. Diabetes Care 24 6 (2001) 1023-1028
130. Krakoff J., Lindsay R.S., Looker H.C., Nelson R.G., Hanson R.L., and Knowler W.C. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 26 1 (2003) 76-81
131. Lee E.T., Lu M., Bennett P.H., and Keen H. Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl. 2 (2001) S78-81
132. Lee E.T., Howard B.V., Wang W., Welty T.K., Galloway J.M., Best L.G., et al. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. Circulation 113 25 (2006) 2897-2905
133. Rith-Najarian S.J., Valway S.E., and Gohdes D.M. Diabetes in a northern Minnesota Chippewa Tribe: Prevalence and incidence of diabetes and incidence of major complications, 1986-1988. Diabetes Care 16 1 (1993) 266-270
134. Schraer C.D., Mayer A.M., Vogt A.M., Naylor J., Brown T.L., Hastie J., et al. The Alaska Native diabetes program. Int. J. Circumpolar Health 60 4 (2001) 487-494
135. Schraer C.D., Adler A.I., Mayer A.M., Halderson K.R., and Trimble B.A. Diabetes complications and mortality among Alaska Natives: 8 years of observation. Diabetes Care 20 3 (1997) 314-321
136. Schraer C.D., Bulkow L.R., Murphy N.J., and Lanier A.P. Diabetes prevalence, incidence, and complications among Alaska Natives, 1987. Diabetes Care 16 1 (1993) 257-259
137. Stahn R.M., Gohdes D., and Valway S.E. Diabetes and its complications among selected tribes in North Dakota, South Dakota, and Nebraska. Diabetes Care 16 1 (1993) 244-247